<img height="1" width="1" style="display:none;" alt="" src="https://dc.ads.linkedin.com/collect/?pid=510762&amp;fmt=gif">
Skip to content
Biker.png
Dave FoxJuly 25, 20171 min read

Are you in the Race?

A Robot Will Be Doing Your Job In 5 Years

We have all read this click bait title many times over. 

Yes, we are at the dawn of the autonomous revolution and ultimately, some jobs will be replaced by robots. The good news is that this revolution is going to accelerate science and technology at a rapid pace. The companies and individuals who invest and embrace automation will have a large competitive advantage over those who stick to traditional techniques.

Biker.png

The science and technology industry is a race! First to the finish line, reaps the rewards; large profits, high stock prices, and the ability to continue innovative research. To increase the likelihood of being first you need access to more information than your competition. To accomplish this, companies must automate their processes. Businesses that invest in automation will be able to create data faster and financially, smarter. Scientist and engineers will spend more time analyzing data and making decisions of what research to explore rather than creating the data. This in turn, will be lead to new discoveries, drugs, treatments, and knowledge. It is quite an exciting time to be in research! Don’t get left behind pedaling, put a motor on that bike and join the race!

Interested in speeding up your viscosity testing? RheoSense can advance you into the race with our automatic, high-throughput viscometer, VROC® initium!

The VROC initium, the first automatic viscometer, is revolutionizing viscosity characterization. Equipped with automatic sample loading and sample cleaning, VROC initium measures absolute viscosity as a function of shear rate across a wide temperature range. This allows unique viscosity fingerprinting of your samples. Samples in 96 well plate as well as 40 vial racks can be tested automatically with our intuitive software.

Measuring viscosity for sample volumes as little as 26 microliters makes early stage development of protein therapeutics cost effective. Automatic intrinsic viscosity measurements provide size of molecules in various formulations in various conditions which help shorten development time significantly.

Written By: Dave Fox, RheoSense Regional Sales Manager

Dave Fox

Dave is a Technical Specialist with RheoSense, Inc.

COMMENTS